# Hefei High-tech VC

> Hefei High-tech VC is a VC fund in Hefei backing Manufacturing and Automotive. See 49 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hefei, China
- Total investments: 49
- Last investment: Jul 2026
- Lead investor: 33%
- Last updated: Aug 2026
- Website: http://www.hfgxt.com.cn/

Hefei High-tech VC is a VC fund in Hefei focused on Manufacturing and Automotive. Hefei High-tech VC is also the only professional venture capital management organization

## Contacts

5 contacts available for Hefei High-tech VC. Shizune tracks 1 team members at Hefei High-tech VC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hefei-high-tech-vc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 8 | 16% |
| Automotive | 3 | 6% |
| Electronics | 3 | 6% |
| Health Care | 3 | 6% |
| Biotechnology | 3 | 6% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 18% |
| Series B | 7 | 14% |
| Series A | 4 | 8% |
| Angel | 3 | 6% |
| Venture - Series Unknown | 3 | 6% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 27 | 55% |
| Japan | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chen Jianguo | Deputy General Manager | 2 | https://shizune.co/investors/profile/chen-jianguo-e083 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aixin Semiconductor Technology | Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. |  | Series B | Jul 20, 2026 |  |
| StarNuclear Fusion | StarNuclear Fusion is focused on the "high-temperature superconductivity + advanced quasi-isotropic propulsion (QI)" stellarator technology roadmap. | $122.3M | Series A | Jun 30, 2026 |  |
| Zero Gravity Aircraft Industry | Zero Gravity Aircraft Industry is engaged in the R&D and manufacturing of eVTOL aircraft. | $74M | Series B | Jun 17, 2026 |  |
| Origin Quantum | Origin Quantum is a full-stack quantum computing company. | $442.5M | Venture - Series Unknown | Jun 08, 2026 |  |
| HiDreamai | HiDreamai is an application developer and multimodal content creator. It will examine the development of representative AIGC basic models and analyze multimodal content generation technologies, with a focus on multimodal interaction and generation that is visual and linguistic. | $73.3M | Series B | Apr 15, 2026 |  |
| Jihui Innovation | Jihui Innovation focuses on the research, development, and industrialization of advanced core materials for all-solid-state batteries, with a particular specialization in lithium battery technologies, aiming to enhance energy density, safety, and performance to support the next generation of energy storage solutions across electric vehicles,consumer electronics, and renewable energy systems. | $1.4M | Angel | Mar 13, 2026 |  |
| Juque Electronics | Juque Electronics is a research and development company offering iteration, defect detection, and testing equipment upgrading solutions. |  | Venture - Series Unknown | Mar 10, 2026 |  |
| Audfly Technology | Audfly Technologies is China's leading acoustic revolutionary technology firm. It is a global audio solutions leader and one of the main authorities on directed audio technology. Since early 2016, Audfly Technologies has been manufacturing and installing Audfly directional speakers for large corporations and industries all around the world. |  | Series B | Mar 02, 2026 |  |
| Regend Therapeutics | Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company inChina to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem cells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health. | $50.6M | Series C | Feb 11, 2026 |  |
| Worg Pharmaceuticals | Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases. | $42.6M | Series D | Dec 22, 2025 |  |

10 of 49 investments shown.

## Co-investors
- [Hefei Industry Investment Group](https://shizune.co/investors/profile/hefei-industry-investment-group) — VC Fund, 9 deals together
- [Hefei Hi-Tech Venture Capital](https://shizune.co/investors/profile/hefei-hi-tech-venture-capital) — VC Fund, 5 deals together
- [Hefei Innovation Investment](https://shizune.co/investors/profile/hefei-innovation-investment) — VC Fund, 5 deals together
- [HKUST Silicon Valley Guidance Fund](https://shizune.co/investors/profile/hkust-silicon-valley-guidance-fund) — VC Fund, 5 deals together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 4 deals together
- [Xunfei Venture Capital](https://shizune.co/investors/profile/xunfei-venture-capital) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Hefei High-tech VC invest in?

Hefei High-tech VC invests primarily in Manufacturing, Automotive and Electronics startups, most often at Seed and Series B stage. Most of the 49 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Hefei High-tech VC?

Public channels for Hefei High-tech VC include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hefei High-tech VC?

The team at Hefei High-tech VC includes Chen Jianguo (Deputy General Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co